Cargando…
New‐user and prevalent‐user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices
BACKGROUND: Guidance reports for observational comparative effectiveness and drug safety research recommend implementing a new‐user design whenever possible, since it reduces the risk of selection bias in exposure effect estimation compared to a prevalent‐user design. The uptake of this guidance has...
Autores principales: | Luijken, Kim, Spekreijse, Judith J., van Smeden, Maarten, Gardarsdottir, Helga, Groenwold, Rolf H. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252086/ https://www.ncbi.nlm.nih.gov/pubmed/33899305 http://dx.doi.org/10.1002/pds.5258 |
Ejemplares similares
-
Quality of reporting of drug exposure in pharmacoepidemiological studies
por: Hempenius, Mirjam, et al.
Publicado: (2020) -
Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact
por: Hempenius, Mirjam, et al.
Publicado: (2021) -
Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions
por: Hempenius, Mirjam, et al.
Publicado: (2019) -
A systematic review of how missing data are handled and reported in multi‐database pharmacoepidemiologic studies
por: Hunt, Nicholas B., et al.
Publicado: (2021) -
Incidence in pharmacoepidemiology—Basic definitions and types of misclassification
por: Hoffmann, Mikael, et al.
Publicado: (2022)